Navigation Links
DC Patients' Cooperative Urges Changes to the Proposed Medical Cannabis 'Marijuana' Regulations
Date:9/20/2010

WASHINGTON, Sept. 20 /PRNewswire-USNewswire/ -- The District of Columbia Patients' Cooperative (DCPC), a non-profit, medical cannabis organization registered in the District of Columbia, has submitted comments to the Office of the DC Attorney General addressing numerous issues on proposed regulations announced 45 days ago.  

DCPC's comments may be viewed online at http://www.dcpatients.org/DCPC_comments.pdf along with the comments of cannabis advocacy groups including Americans for Safe Access and the Marijuana Policy Project.  

DCPC's is the only major local organization addressing practical changes needed to implement a sustainable non-profit model.  

Major issues addressed in DCPC's comments include:

  1. DCPC wants the DOH, not ABRA, to regulate medical cannabis.
  2. Best applicants should be selected for licenses and not on a first-come, first-served basis.
  3. Proposed regulations do not distinguish between for profit, non-profit, and individual applicants.
  4. Best practices used in other states are being ignored pertaining to caregivers.
  5. Police potentially have access to patient records at dispensaries.
  6. Numerous free speech issues for physicians and unfair dispensary signage restrictions.
  7. Non-refundable application fees 50 times greater than DC's pharmacy license.
  8. Fees 4 to 6 six times greater than annual licenses of analogous ABRA approved alcohol establishments.
  9. The number of cultivation centers is arbitrarily limited when anticipated demand is not known.
  10. Officials are not required to wear protective clothing during inspection of cultivation centers.
  11. Proposed regulations do not address re-imbursement for medicine provided to low income patients.

The District Council has until October 19, 2010 to approve or disapprove the proposed regulations.  DCPC urges the District Council to thoroughly review the comments submitted by stakeholder organizations and reject portions of the proposed rules that are inconsistent with best practices found in other states with implemented medical cannabis programs.

The District of Columbia Patients' Cooperative intends to construct and operate a dispensary in the Adams Morgan neighborhood and will be seeking a license for both a dispensary and cultivation center in the coming months.  In order to ensure the viability and sustainability of the District's medical cannabis program, it is imperative that significant changes are made to the proposed regulations.


'/>"/>
SOURCE DC Patients Cooperative
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Investigational Compound Once-Daily Lixisenatide Demonstrated Significant Improvement in Glucose Control in Patients with Type 2 Diabetes
2. Adding Lantus® to Oral Antidiabetic Drug Therapy Further Reduced Blood Sugar in Patients with Type 2 Diabetes
3. Practical Diabetology Highlights Advanced Lipid Testing for Type 2 Diabetes Patients
4. Tacoma, Colorado Springs and Salt Lake City Have the Highest Percentage of HIV Patients in the U.S. Who Are Left Untreated
5. Tahoma, Colorado Springs and Salt Lake City Have the Highest Percentage of HIV Patients in the U.S. Who Are Left Untreated
6. Obesity Expert to Speak to FDA in Support of Treatment Options for Obese Patients
7. Palmetto Health Richland Hospital Becomes First in South Carolina to Noninvasively, Wirelessly Monitor Patients Using State-of-the-Art Masimo Patient SafetyNet™ System
8. AultCare/Cardiocom® White Paper Shows Telehealth Services Reduce ER Visits and Inpatient Stays for Patients
9. Improvement in Prediction of Blood Clots in Cancer Patients
10. Stereotaxis Announces First-Ever, Prospective, Comparative Clinical Trial Outcome for VT Patients
11. Patients Should Expect Long Life from their Joint Replacements!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017 Avelas Biosciences, Inc., a ... diagnosis through treatment, today announced that Carmine N. Stengone , ... company at the Needham & Company 16 th Annual Healthcare ... a.m. PDT) at the Westin Grand Central Hotel in ... ...
(Date:3/29/2017)... 2017 Research and Markets has announced the addition ... Centers & Forecast" report to their offering. ... Proton Therapy Market in Italy ... in 2016. There are currently three proton therapy centers in ... patients. In Italy , the first patients were treated ...
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets has ... Policy, Patients Treated at Proton Therapy Centers & Forecast" report to ... The South ... its current market size in 2016. The Untapped Proton Therapy Market for ... Billion USD in 2016. Proton Therapy plays an important ...
Breaking Medicine Technology:
(Date:3/29/2017)... Amherst, Massachusetts (PRWEB) , ... March 30, 2017 , ... ... has had great success and feedback from high school and college students who have ... is being held July 7-23 and YFI is now accepting applications for enrollment. ...
(Date:3/29/2017)... (PRWEB) , ... March 30, 2017 , ... Sports Brand ... brace, which retails normally at $29.97; for the remaining days of March, the ... also been reduced to a special price of just $10 (regular retail price $19.97). ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... at a Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and ... two southeastern states. Ingredients in HeartBoost, an over the counter heart healthy drink, ...
(Date:3/29/2017)... ... 2017 , ... Based on research from Guardian’s Fourth Annual ... trying to balance both short-term and long-term benefits demands. Are employers struggling ... complexity, companies are finding that the short-term strategies used to control costs, improve ...
(Date:3/29/2017)... Horeb, WI (PRWEB) , ... March 29, 2017 , ... ... patients on early orthodontic treatment and accepting new pediatric patients, with or without a ... help young patients have a better orthodontic outcome and experience. When patients receive early ...
Breaking Medicine News(10 mins):